首页> 外文期刊>Analytical methods >Pyrrolizidine alkaloid profile in a traditional Chinese herbal medicine Chuan Zi Wan (Ligulariae Radix et Rhizoma) by liquid chromatography/ electrospray ionization ion trap mass spectrometry
【24h】

Pyrrolizidine alkaloid profile in a traditional Chinese herbal medicine Chuan Zi Wan (Ligulariae Radix et Rhizoma) by liquid chromatography/ electrospray ionization ion trap mass spectrometry

机译:液相色谱/电喷雾电离离子阱质谱法研究中药川子丸中吡咯烷核生物碱的分布

获取原文
获取原文并翻译 | 示例
           

摘要

Chuan Zi Wan (CZW) is a traditional Chinese herbal medicine derived from Ligularia species and used as an antitussive and expectorant folk remedy. Its toxicity was recently demonstrated in rats, for which the hepatotoxic pyrrolizidine alkaloids (PAs) were detected but not fully examined. In order to further assess its safety, the entire PA profile of CZW was investigated using high-performance liquid chromatography (HPLC) coupled to electrospray ionization ion trap mass spectrometry. Twenty-six toxic PAs (25 otonecine-type and one retronecine-type PAs) and one non-toxic PA of platynecine-type were detected and/or characterized based on diagnostic ions, mass fragmentation patterns, chromatographic behaviors and biosynthetic consideration. Except clivorine, ligularine, hodgsonine and ligularizine, all other PAs were described for the first time; moreover, most otonecine-type PAs were found to contain the acetyl group, an important substructure closely linked to their toxic effects in vivo. Clivorine was unequivocally identified as a major PA in the extract, with a content of 3.94 mg g~(-1) dried extractant determined by a HPLC/UV assay. The total content of the toxic PAs was estimated to be about 7.92 mg g~(-1) dried extract. These results indicated that this herbal product may have a potential health threat to humans in its Chinese medical practice.
机译:川Wan丸(CZW)是源自Li草属的传统中草药,被用作镇咳药和祛痰药。最近在大鼠中证明了其毒性,已检测到肝毒性吡咯并立核生物碱(PAs),但尚未对其进行全面检查。为了进一步评估其安全性,使用高效液相色谱(HPLC)与电喷雾电离离子阱质谱联用,研究了CZW的整个PA曲线。根据诊断离子,质量碎片模式,色谱行为和生物合成考量,检测和/或鉴定了26种有毒PA(25种为Otonecine型和1种为Renenecine型PA)和一种为Pnetancine型无毒PA。除长春碱,利古丁,​​霍奇森和利古拉嗪外,所有其他PA均是首次描述。此外,发现大多数的Ocinecine型PA都含有乙酰基,这是与其体内毒性作用密切相关的重要亚结构。明确地确定了草精碱是提取物中的主要PA,通过HPLC / UV分析测定的含量为3.94 mg g〜(-1)干燥提取剂。有毒PA的总含量估计为约7.92 mg g〜(-1)干燥提取物。这些结果表明,该草药产品在其中医实践中可能对人类健康构成潜在威胁。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号